Fedai Özcan | Clinical Medicine | Innovative Research Award

Innovative Research Award

Fedai Özcan

Fedai Özcan is affiliated with Klinikum Dortmund, Germany, and works within the field of Clinical Medicine. His academic profile is presented in connection with the Innovative Research Award by Health Scientists Awards, recognizing the importance of clinical research, scientific advancement, evidence-based medical practice, and contributions toward improving healthcare quality and patient outcomes.

Fedai Özcan
Affiliation Klinikum Dortmund
Country Germany
Subject area Clinical Medicine
Award Innovative Research Award
Event Health Scientists Awards
ORCID 0000-0003-4312-7784

Abstract

Fedai Özcan is identified with Klinikum Dortmund, Germany, in the field of Clinical Medicine. This academic recognition profile presents his professional affiliation and the context of the Innovative Research Award associated with Health Scientists Awards. Clinical medicine encompasses patient assessment, diagnosis, treatment, and the evaluation of approaches that may improve healthcare delivery. Research innovation in this field can involve clinical methods, evidence-based practice, diagnostic strategies, and patient-centred outcomes. A comprehensive assessment of individual contributions requires verified publications, research records, and supporting evidence. These details have not been supplied for this profile and should be confirmed through authoritative sources before publication.[2]

Keywords

Clinical medicine, clinical research, innovative research, evidence-based medicine, patient-centred care, medical research, clinical practice, healthcare outcomes, medical innovation, translational medicine, diagnostic approaches, therapeutic strategies, healthcare quality, research evaluation, scientific recognition.

Introduction

Fedai Özcan is associated with Klinikum Dortmund in Germany and is presented in the subject area of Clinical Medicine. Clinical medicine applies scientific evidence to the prevention, diagnosis, management, and monitoring of disease. Research in this discipline supports the evaluation of clinical practices, the refinement of treatment pathways, and the identification of opportunities to improve patient care. Professional affiliations and researcher identifiers can help readers distinguish academic records and locate relevant scholarly outputs. The ORCID registry provides a persistent identifier for connecting researchers with their professional activities, while publication databases support the discovery of indexed research literature. [1] [2]

Research Profile

Fedai Özcan’s supplied professional profile identifies Klinikum Dortmund, Germany, as his institutional affiliation and Clinical Medicine as his subject area. A detailed account of his clinical responsibilities, specialist interests, academic appointments, and research methods requires additional verified biographical information. ORCID can provide a persistent researcher identifier and may link to records maintained by the researcher or connected scholarly systems. Publication and citation information should be checked against authoritative bibliographic records rather than estimated. [1]

Research Contributions

Fedai Özcan’s specific research contributions cannot be established from the supplied information alone. In clinical medicine, contributions may be assessed through documented clinical studies, peer-reviewed publications, methodological advances, collaborative projects, and evidence of relevance to patient care. Appropriate evaluation considers study design, reproducibility, ethical oversight, and the strength of the evidence supporting reported findings. Individual achievements should be described only when supported by publications, institutional records, or other reliable documentation. These standards help maintain a balanced account of clinical scholarship without attributing unverified discoveries or outcomes to a researcher.

Publications

No publication list, article titles, or digital object identifiers were included in the supplied researcher information. Consequently, specific papers cannot be attributed to Fedai Özcan reliably in this article. Relevant publications should be identified through verified author records and checked against publisher pages or bibliographic databases. Each listed work should include its full title, author sequence, publication venue, year, and DOI when available. Crossref provides a searchable bibliographic metadata service that can assist with locating publication records and validating DOI information. [3]

Research Impact

The impact of clinical research may be examined through scholarly citations, independent replication, implementation in clinical practice, contributions to guidelines, and measurable improvements in patient outcomes. Citation counts and h-index values offer limited quantitative indicators and should be interpreted alongside research quality, disciplinary conventions, authorship, and publication history. No verified bibliometric measurements or documented clinical outcomes have been supplied for Fedai Özcan. Accordingly, this profile does not assign numerical impact values or claim specific changes in healthcare attributable to his work. Reliable assessment requires traceable publications and independently verifiable evidence.[2]

Award Suitability

The Innovative Research Award associated with Health Scientists Awards provides a recognition context for research and scientific contributions. Evaluating a candidate in Clinical Medicine should involve documented originality, methodological rigour, scientific significance, ethical research practices, and potential relevance to clinical care. Fedai Özcan’s institutional affiliation and subject area are provided for this profile, but specific achievements and supporting publications have not been independently established here. A defensible assessment of award suitability should therefore incorporate verified research outputs, evidence of individual contribution, and the award organiser’s published eligibility and evaluation criteria.

Conclusion

Fedai Özcan is presented in this academic recognition profile as a Clinical Medicine professional affiliated with Klinikum Dortmund, Germany. The article outlines the relevance of clinical research, the principles used to evaluate scholarly contributions, and the evidence needed to document research impact. His ORCID identifier provides a route for checking researcher records, while verified publications and institutional sources are necessary to establish specific achievements. Further bibliographic and professional information would support a more comprehensive account of his research activities and provide a stronger evidence base for assessing recognition in the context of the Innovative Research Award.[2]

References

    1. ORCID. (n.d.). ORCID: Fedai Özcan. ORCID.
      https://orcid.org/0000-0003-4312-7784
    2. Özcan, F., Kiziler, F., Brinkkoetter, P., Kühne, L., Knöbl, P., & Brinkhoff, A. (n.d.). Unintended interruption of caplacizumab therapy can compromise outcomes in immune-mediated thrombotic thrombocytopenic purpura: Lessons from two clinical cases.
      https://www.mdpi.com/2077-0383/15/17/6601
    3. Özcan, F., Kiziler, F., & Brinkhoff, A. (n.d.). Acute phosphate nephropathy after oral sodium phosphate bowel preparation: A clinically underrecognized entity illustrated by a series of biopsy-proven cases..
      https://www.preprints.org/manuscript/202609.0439
    4. Health Scientists Awards. (n.d.). Official award website. Health Scientists Awards.
      https://healthscientists.org/

Waseem Hajjar | Clinical Medicine | Innovative Research Award

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Jaehoon Lee | Clinical Medicine | Innovative Research Award

Innovative Research Award

Jaehoon Lee
Affiliation Clinical Medicine; vascular and endovascular surgery
Country South Korea
Google Scholar View Profile
Documents 25
Citations 155
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0906-5236

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Abstract

Jaehoon Lee is a South Korean clinical medicine researcher whose documented work focuses on vascular and endovascular surgery. His publications address endovascular aneurysm repair, peripheral arterial disease, femorofemoral bypass, arteriovenous access thrombosis, and emerging procedural approaches. The research emphasizes anatomical assessment, graft performance, procedural feasibility, postoperative complications, and clinical outcomes. His studies include retrospective analyses, case-based investigations, and multicenter prospective research, reflecting an applied approach to vascular care. The publication record demonstrates sustained interest in improving revascularization strategies, evaluating vascular devices, and identifying factors associated with treatment outcomes. These contributions support consideration for an Innovative Research Award in Clinical Medicine.

Keywords

Vascular surgery; endovascular surgery; peripheral arterial disease; endovascular aneurysm repair; abdominal aortic aneurysm; femorofemoral bypass; saphenous vein graft; polytetrafluoroethylene; vascular access; arteriovenous fistula; thrombosis; rotational atherectomy; infrainguinal arterial disease; revascularization; graft patency; iliac branch device; arterial anatomy; vascular devices; clinical outcomes; postoperative complications; predictive modeling; machine learning; atherosclerosis; clinical medicine.

Introduction

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Research Profile

Jaehoon Lee’s research profile centers on vascular and endovascular surgery, with publications involving abdominal aortic aneurysm repair, femorofemoral bypass, arteriovenous access, and infrainguinal arterial disease. His documented work reflects clinically oriented investigation, retrospective and multicenter study designs, procedural assessment, and evaluation of anatomical or treatment factors affecting outcomes today broadly. [2]

Research Contributions

Jaehoon Lee has contributed to clinical vascular research through studies evaluating endovascular aneurysm repair, graft selection, vascular access thrombosis, and contemporary peripheral interventions. His publications examine technical feasibility, anatomical change, graft patency, postoperative complications, and longer-term clinical outcomes, providing evidence relevant to decision-making in vascular surgery practice and patient care. [3]

Publications

Jaehoon Lee’s documented publication record includes research on changes following endovascular aneurysm repair, custom-made iliac branch devices, femorofemoral bypass graft selection, postoperative thrombosis of arteriovenous access, and predictive modeling of arteriovenous fistula occlusion. Recent multicenter research also examines rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease. [1] [2]

Research Impact

Jaehoon Lee’s research has clinical relevance because vascular diseases require durable revascularization, careful anatomical assessment, and management of procedure-related complications. His studies address these needs through outcome-oriented analyses of bypass grafts, endovascular repair, dialysis access, and peripheral arterial interventions, supporting evidence-based refinement of vascular surgical and endovascular practice clinically directly. [3] [4]

Award Suitability

Jaehoon Lee demonstrates a research portfolio aligned with Innovative Research Award consideration in Clinical Medicine, particularly vascular and endovascular surgery. His documented studies investigate procedural strategies, device applications, graft alternatives, predictive modeling, and multicenter peripheral arterial treatment. The portfolio shows sustained clinical investigation and practical relevance to contemporary vascular care.[5]

Conclusion

Jaehoon Lee’s documented research demonstrates a consistent clinical focus on vascular and endovascular medicine, spanning aneurysm repair, peripheral arterial disease, bypass surgery, vascular access, and procedural innovation. The available publication record supports recognition of a clinically relevant research program that connects technical investigation with patient-centered outcomes and evolving vascular practice.[4]

References

  1. Lee JH, Park KH, Kwak SG. Changes in Neck Angle, Neck Length, Maximum Diameter, Maximum Area and Thrombus after Endovascular Aneurysm Repair. Vascular Specialist International. https://doi.org/10.5758/vsi.190054
  2. Park YE, Lee JH, Yun WS, Park KH. Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2014.29.12.1678
  3. Kwon G, Park KH, Kwak SG, Lee JH. The Results of Femorofemoral Bypass Using a Saphenous Vein Graft as an Alternative to PTFE Grafts. Vascular Specialist International. https://doi.org/10.5758/vsi.220060
  4. Kim J, Park K, Cho Y, Lee J. The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study. International Journal of Environmental Research and Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9690458/
  5. Lee JH, Kwak SG. Development of a Machine Learning-Based Predictive Model for Arteriovenous Fistula Occlusion After Surgery: A Retrospective Cohort Study from 2015 to 2025. Medicina. https://doi.org/10.3390/medicina61122150

Georg Feigl | Clinical Medicine | Research Excellence Award

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
View ORCID Profile

Featured Publications

Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
View Scopus Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
View Scopus Profile

Featured Publications

Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

Mr. Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

lecturer | University of Gondar | Ethiopia

Matiyas Mamo Bekele is an emerging optometry professional and clinical researcher whose work spans community eye health, refractive error–related quality of life, low-vision challenges, spectacle use, and the broader landscape of preventable visual impairment. As an academic and clinician at the University of Gondar, he integrates teaching, research, and service, contributing to the development of future optometrists, ophthalmic nurses, and ophthalmology residents while also providing comprehensive eye care through both static and outreach platforms. His scholarly work demonstrates a strong orientation toward population-based ophthalmic research, with multiple peer-reviewed publications addressing eye care utilization patterns, spectacle coverage, knowledge and attitudes toward vision correction, and the burden of ocular diseases among diverse communities and at-risk groups, including individuals with diabetes. His collaborative projects with multidisciplinary teams across hospitals, academic institutions, and public health units reflect a commitment to generating evidence that informs national strategies for equitable eye health access. Through his engagement in systematic reviews, clinical investigations, and community-focused studies, he contributes to a growing body of knowledge that supports early detection, appropriate referral pathways, and improved service delivery in low-resource settings. His involvement in national professional bodies and international volunteer organizations further underscores his dedication to strengthening training systems, capacity building, and vision-related advocacy. As a research advisor and mentor, he supports emerging scholars in pursuing impactful inquiry that addresses gaps in vision care and public health. His continuing work advances the understanding of refractive error needs, ocular morbidities, and community-based approaches to blindness prevention, positioned toward improving quality of life and reducing avoidable vision loss across broader populations. He has 10 citations from 13 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Hulleck, A. A., Mohan, D. M., Abdallah, N., El Rich, M., & Khalaf, K. (2022). Present and future of gait assessment in clinical practice: Towards the application of novel trends and technologies.

2. Mohan, D. M., Khandoker, A. H., Wasti, S. A., Ismail Alali, S. I. I., & colleagues. (2021). Assessment methods of post-stroke gait: A scoping review of technology-driven approaches to gait characterization and analysis.

3. Jelinek, H. F., Osman, W. M., Khandoker, A. H., Khalaf, K., Lee, S., Almahmeed, W., & colleagues. (2017). Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates.

4. Maschirow, L., Khalaf, K., Al-Aubaidy, H. A., & Jelinek, H. F. (2015). Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes—Biomarkers as a possible tool for early disease detection for rural screening.

5. Witzel, I. I., Jelinek, H. F., Khalaf, K., Lee, S., Khandoker, A. H., & Alsafar, H. (2015). Identifying common genetic risk factors of diabetic neuropathies.

Tana Takacova | Clinical Medicine | Best Researcher Award

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Meng Li | Clinical Medicine | Best Medical Scientist Award

Mr. Meng Li | Clinical Medicine | Best Medical Scientist Award 

professor | Dandong Central Hospital | China

Dr. Meng Li currently serves as a Teaching Secretary and Professor of General Surgery at China Medical University and is also affiliated with Dandong Central Hospital, the largest Grade-A general hospital in the Liaodong region. She earned her Ph.D. in Oncology from China Medical University, one of the leading medical universities in China. Her primary research focuses on digestive tract tumor surgery, hepatobiliary and pancreatic surgery, gastrointestinal oncology, and the comprehensive treatment of malignant tumors. Over the years, Dr. Li has contributed significantly to the medical research community, publishing seven SCI/Scopus-indexed papers, including works on predictive models for intraabdominal infections after radical gastrectomy, gene signatures in hepatocarcinoma prognosis, and gut microbiota’s role in urological cancers. Her research has accumulated over 47 citations and has advanced understanding in cancer surgery and molecular oncology. In recognition of her outstanding contributions, she received the First Prize of the Liaoning Province Science and Technology Progress Award in 2023. Dr. Li actively participates in collaborative projects, including two National Natural Science Foundation programs, and holds memberships in several professional bodies such as the Chinese Anti-Cancer Association and the Chinese Pancreatic Disease Society. She also serves as an Editorial Board Member of the Cancer Research Journal (CRJ), a guest editor for two scientific journals, and a review editor for others, reflecting her strong commitment to scientific advancement and peer review excellence. Her long-term goal is to deepen molecular insights into cancer and improve clinical outcomes through innovative surgical research. He has 213 citations from 17 documents with an h-index of 7.

Profiles: Scopus | ORCID

Featured Publications

1. Feng, Y., Yang, J., Li, M., Tang, L., Sun, S., & Wang, Y. (2024). A Bayesian network for simultaneous keyframe and landmark detection in ultrasonic cine.

2. Li, Z.-W., Wu, J.-T., Bi, Y., Li, M.-M., Naseem, A., Pan, J., Guan, W., Hao, Z.-C., Kuang, H.-X., & Chen, Q.-S. (2024). A new triterpenoid saponin and a new natural saponin from the roots of Bupleurum scorzonerifolium Willd.

3. Yu, X., Feng, B., Wu, J., & Li, M. (2024). A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.

4. Yu, X., Tang, W., Bai, C., Li, R., Feng, B., Wu, J., Guo, X., Chen, H., & Li, M. (2024). A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.

5. Li, M., Zhang, X., Chen, K., Miao, Y., Xu, Y., Sun, Y., Jiang, M., Liu, M., Gao, Y., & Xue, X. (2024). Alcohol exposure and disease associations: A Mendelian randomization and meta-analysis on weekly consumption and problematic drinking.